This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Strategic Education (STRA) Beats Q4 Earnings and Revenue Estimates
by Zacks Equity Research
Strategic Education (STRA) delivered earnings and revenue surprises of 22.63% and 1.59%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?
Afya (AFYA) Advances While Market Declines: Some Information for Investors
by Zacks Equity Research
Afya (AFYA) reachead $20.05 at the closing of the latest trading day, reflecting a +0.3% change compared to its last close.
Afya (AFYA) Gains As Market Dips: What You Should Know
by Zacks Equity Research
Afya (AFYA) closed the most recent trading day at $19.85, moving +1.17% from the previous trading session.
Afya (AFYA) Beats Stock Market Upswing: What Investors Need to Know
by Zacks Equity Research
Afya (AFYA) concluded the recent trading session at $20.51, signifying a +1.13% move from its prior day's close.
Afya (AFYA) Advances While Market Declines: Some Information for Investors
by Zacks Equity Research
In the closing of the recent trading day, Afya (AFYA) stood at $21.02, denoting a +0.57% change from the preceding trading day.
Afya (AFYA) Rises As Market Takes a Dip: Key Facts
by Zacks Equity Research
Afya (AFYA) closed at $20.44 in the latest trading session, marking a +1.79% move from the prior day.
PRDO or AFYA: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
PRDO vs. AFYA: Which Stock Is the Better Value Option?
PRDO vs. AFYA: Which Stock Is the Better Value Option?
by Zacks Equity Research
PRDO vs. AFYA: Which Stock Is the Better Value Option?
Wall Street Analysts Think Afya (AFYA) Is a Good Investment: Is It?
by Zacks Equity Research
Based on the average brokerage recommendation (ABR), Afya (AFYA) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
PRDO or AFYA: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
PRDO vs. AFYA: Which Stock Is the Better Value Option?
Afya (AFYA) Is Considered a Good Investment by Brokers: Is That True?
by Zacks Equity Research
Based on the average brokerage recommendation (ABR), Afya (AFYA) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
Afya (AFYA) Rises Higher Than Market: Key Facts
by Zacks Equity Research
In the closing of the recent trading day, Afya (AFYA) stood at $17.49, denoting a +1.92% change from the preceding trading day.
Afya (AFYA) Beats Stock Market Upswing: What Investors Need to Know
by Zacks Equity Research
Afya (AFYA) concluded the recent trading session at $17.16, signifying a +0.35% move from its prior day's close.
Afya (AFYA) Stock Drops Despite Market Gains: Important Facts to Note
by Zacks Equity Research
Afya (AFYA) concluded the recent trading session at $16.10, signifying a -0.86% move from its prior day's close.
Afya (AFYA) Advances While Market Declines: Some Information for Investors
by Zacks Equity Research
In the latest trading session, Afya (AFYA) closed at $16.01, marking a +1.01% move from the previous day.
Afya (AFYA) Gains As Market Dips: What You Should Know
by Zacks Equity Research
In the most recent trading session, Afya (AFYA) closed at $15.48, indicating a +0.13% shift from the previous trading day.
Afya (AFYA) Suffers a Larger Drop Than the General Market: Key Insights
by Zacks Equity Research
In the most recent trading session, Afya (AFYA) closed at $15.43, indicating a -1.03% shift from the previous trading day.
Afya (AFYA) Gains But Lags Market: What You Should Know
by Zacks Equity Research
The latest trading day saw Afya (AFYA) settling at $14.93, representing a +0.74% change from its previous close.
Afya (AFYA) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
Afya (AFYA) closed the most recent trading day at $16.05, moving +1.9% from the previous trading session.
Wall Street Analysts See Afya (AFYA) as a Buy: Should You Invest?
by Zacks Equity Research
According to the average brokerage recommendation (ABR), one should invest in Afya (AFYA). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?
Afya (AFYA) Q2 Earnings Lag Estimates
by Zacks Equity Research
Afya (AFYA) delivered earnings and revenue surprises of -12.12% and 1.71%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?
Afya (AFYA) Gains But Lags Market: What You Should Know
by Zacks Equity Research
In the latest trading session, Afya (AFYA) closed at $14.71, marking a +0.41% move from the previous day.
Is It Worth Investing in Afya (AFYA) Based on Wall Street's Bullish Views?
by Zacks Equity Research
According to the average brokerage recommendation (ABR), one should invest in Afya (AFYA). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?
Entravision Communications (EVC) Extends Partnership With NFL
by Zacks Equity Research
Entravision Communications (EVC) extends its partnership with the NFL for the ninth consecutive season, securing exclusive national Spanish radio broadcast rights.
Afya (AFYA) Stock Moves -0.55%: What You Should Know
by Zacks Equity Research
Afya (AFYA) closed the most recent trading day at $14.57, moving -0.55% from the previous trading session.